Literature DB >> 34985825

Return-to-baseline multiple imputation for missing values in clinical trials.

Yongming Qu1, Biyue Dai1.   

Abstract

Return-to-baseline is an important method to impute missing values or unobserved potential outcomes when certain hypothetical strategies are used to handle intercurrent events in clinical trials. Current return-to-baseline approaches seen in literature and in practice inflate the variability of the "complete" dataset after imputation and lead to biased mean estimators when the probability of missingness depends on the observed baseline and/or postbaseline intermediate outcomes. In this article, we first provide a set of criteria a return-to-baseline imputation method should satisfy. Under this framework, we propose a novel return-to-baseline imputation method. Simulations show the completed data after the new imputation approach have the proper distribution, and the estimators based on the new imputation method outperform the traditional method in terms of both bias and variance, when missingness depends on the observed values. The new method can be implemented easily with the existing multiple imputation procedures in commonly used statistical packages.
© 2022 John Wiley & Sons Ltd.

Entities:  

Keywords:  baseline observation carried forward; direct maximum likelihood estimation; estimand; ignorable missingness

Mesh:

Year:  2022        PMID: 34985825     DOI: 10.1002/pst.2191

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  1 in total

1.  Impact of Using A Mixed Data Collection Modality on Statistical Inferences in Decentralized Clinical Trials.

Authors:  Alexandra Curtis; Yongming Qu
Journal:  Ther Innov Regul Sci       Date:  2022-05-24       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.